Free NAPLEX Practice Test: 100 Questions With Answers and Rationales
These 100 original, unofficial questions follow the current NAPLEX weights: 25 / 25 / 40 / 5 / 5 across NABP's five content domains, per the NAPLEX Content Outline effective May 1, 2025. Answer each question before you read the explanation and source that follow it. No signup, no email.
Practice questions
Question 1
Domain 3: Person-Centered Assessment and Treatment Planning · 3.E.2 Medication use, storage, and disposal · Multiple choice
A patient takes levothyroxine 100 mcg at 7 a.m. and a calcium carbonate supplement with breakfast at 7:15 a.m. Her TSH has risen since she started the calcium. What is the best counseling recommendation?
Reveal answer and explanation for question 1
Correct answer: C. Calcium carbonate binds levothyroxine in the gut and lowers absorption. The levothyroxine labeling says to take it at least 4 hours before or after products containing calcium carbonate or iron. Taking levothyroxine on an empty stomach in the morning and calcium later in the day fixes the problem without dropping the supplement.
Why the other options are wrong:
- A: Food and calcium both reduce levothyroxine absorption; this makes the problem worse.
- B: One hour does not meet the labeled 4-hour separation.
- D: Stopping calcium is unnecessary. Spacing the doses solves the interaction, and she may need the calcium.
Remember: Levothyroxine: empty stomach, then 4 hours away from calcium carbonate or iron.
Source: Levoxyl (levothyroxine) patient information, Pfizer — How should I take LEVOXYL?
Question 2
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.2 Quantities of drugs to be dispensed or administered · Fill in the blank
A prescription reads: amoxicillin oral suspension 250 mg/5 mL, 500 mg by mouth three times daily for 10 days. How many milliliters should be dispensed?
Your answer: ______ mL
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 2
Correct answer: 300 mL. 500 mg ÷ (250 mg/5 mL) = 10 mL per dose. 10 mL × 3 doses/day × 10 days = 300 mL.
Remember: Convert the dose to a volume first, then multiply by doses per day and days.
Source: Worked calculation from the values in the question.
Question 3
Domain 2: Medication Use Process · 2.A.1 Drug names and therapeutic classes · Multiple choice
A patient hands you a prescription for Entresto. Which option correctly identifies its ingredients and drug class?
Reveal answer and explanation for question 3
Correct answer: C. Entresto contains sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker. Together they form the ARNI class used in heart failure.
Why the other options are wrong:
- A: No marketed product pairs sacubitril with amlodipine.
- B: Valsartan/HCTZ is Diovan HCT, not Entresto.
- D: Ivabradine is Corlanor, a separate heart failure drug.
Remember: Entresto = sacubitril + valsartan = ARNI.
Source: Entresto prescribing information (DailyMed) — Title and Section 1, Indications
Question 4
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.B.1 Nonsterile preparations · Multiple choice
A pharmacy compounds an oral suspension from commercial tablets in a vehicle that contains a preservative. The water activity is ≥0.60, and there is no USP monograph or preparation-specific stability data. Under USP <795>, what is the longest beyond-use date (BUD) the pharmacy may assign?
Reveal answer and explanation for question 4
Correct answer: A. When no monograph or preparation-specific stability data exist, USP <795> sets default BUD limits by type of preparation. A preserved aqueous dosage form (water activity ≥0.60) is limited to 35 days, stored at controlled room temperature or in a refrigerator.
Why the other options are wrong:
- B: 14 days (refrigerated) is the limit for a NONpreserved aqueous dosage form.
- C: 90 days is the limit for a nonaqueous oral liquid (water activity <0.60).
- D: 180 days is the limit for other nonaqueous dosage forms, such as capsules or suppositories.
Remember: USP <795> defaults: nonpreserved aqueous 14 d (fridge) · preserved aqueous 35 d · nonaqueous oral liquid 90 d · other nonaqueous 180 d.
Source: USP <795> beyond-use date limits (USP slides hosted by NABP) — Slides 19-20, BUD table
Question 5
Domain 2: Medication Use Process · 2.C.1 Immunizations: indications and scheduling · Multiple choice
An immunocompetent 54-year-old receives the first dose of recombinant zoster vaccine (Shingrix) today. When should the second dose be given?
Reveal answer and explanation for question 5
Correct answer: B. CDC recommends 2 doses of recombinant zoster vaccine for immunocompetent adults aged 50 and older, separated by 2 to 6 months. If more than 6 months pass, give the second dose as soon as possible; do not restart the series.
Why the other options are wrong:
- A: Shingrix is a 2-dose series.
- C: A 1-2 month interval can be used for people who are or will be immunocompromised, not routinely for this patient.
- D: 12 months is outside the recommended window.
Remember: Shingrix: 2 doses, 2-6 months apart, age 50+ (or 19+ if immunocompromised).
Source: CDC, Shingles Vaccine Recommendations — Routine recommendations
Case A (Questions 6–7)
RJ is a 68-year-old man with heart failure with reduced ejection fraction (LVEF 30%), type 2 diabetes, hypertension, and knee osteoarthritis. Current medications: carvedilol 25 mg BID; sacubitril/valsartan 97/103 mg BID; furosemide 40 mg daily; empagliflozin 10 mg daily; diltiazem ER 180 mg daily (started at urgent care for blood pressure); pioglitazone 30 mg daily; metformin 1,000 mg BID; and OTC naproxen 220 mg BID. Today: BP 138/82 mm Hg, HR 64 bpm, eGFR 24 mL/min/1.73 m², potassium 4.6 mEq/L, A1C 7.8%.
Question 6
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.2 Appropriateness of therapy · Multiple response
Refer to Case A. Which of RJ's current medications should be stopped because they can worsen heart failure with reduced ejection fraction? (Select ALL that apply.)
Reveal answer and explanation for question 6
Correct answer: C, D, F. The 2022 AHA/ACC/HFSA heart failure guideline lists nondihydropyridine calcium channel blockers (diltiazem, verapamil), thiazolidinediones (pioglitazone), and NSAIDs (naproxen) as harmful in HFrEF. Diltiazem is negatively inotropic, pioglitazone causes fluid retention, and NSAIDs promote sodium and water retention and worsen HF symptoms.
Why the other options are wrong:
- A: SGLT2 inhibitors such as empagliflozin are recommended in HFrEF; keep it.
- B: Sacubitril/valsartan is recommended HFrEF therapy; keep it.
- E: Carvedilol is an evidence-based beta-blocker for HFrEF; keep it.
Remember: In HFrEF, remember the 'harm' list: diltiazem/verapamil, TZDs, NSAIDs (plus class IC antiarrhythmics and dronedarone).
Source: 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure — Section 7.3.7, drugs that may worsen HF
Question 7
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.4 Errors and omissions · Multiple choice
Refer to Case A. What is the most appropriate recommendation for RJ's metformin?
Reveal answer and explanation for question 7
Correct answer: C. Metformin labeling lists severe renal impairment (eGFR below 30 mL/min/1.73 m²) as a contraindication because of lactic acidosis risk. RJ's eGFR is 24, so metformin should be stopped, and the team should choose another glucose-lowering option.
Why the other options are wrong:
- A: Continuing it ignores a labeled contraindication.
- B: Dose reduction does not remove a contraindication at eGFR <30.
- D: Contrast-related holds apply to patients who can otherwise take metformin; RJ cannot.
Remember: Metformin: contraindicated at eGFR <30; don't start at eGFR 30-45.
Source: Metformin hydrochloride tablets prescribing information (DailyMed) — Section 4, Contraindications; Section 2, renal dosing
Question 8
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.1 Patient parameters or laboratory measures · Fill in the blank
Estimate creatinine clearance with the Cockcroft-Gault equation for a 72-year-old woman who weighs 60 kg (use this actual body weight) with a serum creatinine of 1.2 mg/dL.
Your answer: ______ mL/min
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 8
Correct answer: 40 mL/min. CrCl = [(140 − age) × weight] ÷ (72 × SCr) × 0.85 for females. (140 − 72) × 60 = 4,080. 72 × 1.2 = 86.4. 4,080 ÷ 86.4 = 47.22. 47.22 × 0.85 = 40.14, which rounds to 40 mL/min.
Remember: Cockcroft-Gault: multiply by 0.85 for females, and use the weight the question tells you to use.
Source: Cockcroft DW, Gault MH. Nephron. 1976;16:31-41 — Original equation
Question 9
Domain 2: Medication Use Process · 2.A.4 Prescription regulations · Multiple response
Which serious risks are included in the boxed warning for systemic fluoroquinolones such as levofloxacin? (Select ALL that apply.)
Reveal answer and explanation for question 9
Correct answer: A, B, C, D. The fluoroquinolone boxed warning covers disabling and potentially irreversible reactions, including tendinitis and tendon rupture, peripheral neuropathy, and CNS effects, plus possible exacerbation of muscle weakness in patients with myasthenia gravis.
Why the other options are wrong:
- E: QT prolongation is a labeled warning (Warnings and Precautions), not part of the boxed warning.
Remember: Fluoroquinolone box: tendons, nerves, CNS, myasthenia gravis.
Source: Levofloxacin tablets prescribing information (DailyMed) — Boxed Warning; Section 5
Question 10
Domain 3: Person-Centered Assessment and Treatment Planning · 3.B Health histories, screenings, and assessments · Multiple choice
A nonpregnant adult's A1C at a health screening is confirmed on repeat testing. Which A1C result meets the ADA diagnostic threshold for diabetes?
Reveal answer and explanation for question 10
Correct answer: B. The ADA Standards of Care use an A1C of 6.5% or higher as a diagnostic criterion for diabetes (confirmed by repeat testing unless there is clear clinical diagnosis). An A1C of 5.7% to 6.4% indicates prediabetes.
Why the other options are wrong:
- A: 5.7% is the lower bound of the prediabetes range.
- C: 6.0% falls in the prediabetes range.
- D: 5.4% is below the prediabetes range.
Remember: A1C: <5.7 normal · 5.7-6.4 prediabetes · ≥6.5 diabetes.
Source: ADA Standards of Care in Diabetes—2026 (Diabetes Care, Supplement 1) — Section 2, Diagnosis and Classification
Question 11
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.E Research design principles and biostatistics · Multiple choice
A randomized trial reports a hazard ratio of 0.91 (95% confidence interval 0.82 to 1.07) for the primary outcome with a new drug compared with placebo. What is the correct interpretation?
Reveal answer and explanation for question 11
Correct answer: A. For ratios (hazard ratio, relative risk, odds ratio), 1 means no difference. A 95% confidence interval that crosses 1 means the data are consistent with no effect, so the result is not statistically significant at α = 0.05.
Why the other options are wrong:
- B: A point estimate of 0.91 suggests a 9% reduction, but the interval includes no effect, so significance is not shown.
- C: A ratio below 1 is not enough; the whole interval must exclude 1.
- D: 1.07 is only the upper limit of the interval, not the estimated effect.
Remember: Ratio CI includes 1 → not significant. Difference CI includes 0 → not significant.
Source: BMJ, Statistics at Square One — Chapters on confidence intervals
Question 12
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.3 Interactions · Multiple choice
A patient who takes simvastatin 40 mg daily receives a new prescription for clarithromycin 500 mg BID for 10 days. What is the most appropriate pharmacist action?
Reveal answer and explanation for question 12
Correct answer: C. Clarithromycin is a strong CYP3A4 inhibitor. Simvastatin labeling contraindicates use with strong CYP3A4 inhibitors because simvastatin levels rise sharply and myopathy or rhabdomyolysis risk increases. If the macrolide is unavoidable, simvastatin is suspended for the course.
Why the other options are wrong:
- A: Lowering the dose does not make a contraindicated combination acceptable.
- B: The interaction is metabolic (enzyme inhibition), so separating doses does not help.
- D: Monitoring alone does not address a contraindication.
Remember: Simvastatin + strong CYP3A4 inhibitor (clarithromycin, itraconazole, ketoconazole, protease inhibitors) = contraindicated.
Source: Simvastatin tablets prescribing information (DailyMed) — Section 4, Contraindications; Section 7, Drug Interactions
Question 13
Domain 2: Medication Use Process · 2.D Medication handling, storage, stability, and disposal · Multiple choice
A caregiver has three unused fentanyl transdermal patches after a patient's death. No drug take-back option is readily available. How should the patches be disposed of?
Reveal answer and explanation for question 13
Correct answer: D. Fentanyl patch labeling tells patients to fold patches so the sticky side sticks to itself and flush them. Fentanyl is on FDA's flush list for use when a take-back option isn't readily available, because a discarded patch can still kill a child or pet who finds it.
Why the other options are wrong:
- A: The trash method is for most medicines, but flush-list drugs like fentanyl patches should be flushed when take-back isn't available.
- B: Cutting exposes drug and does not prevent accidental exposure.
- C: Keeping unneeded opioids in the home creates misuse and exposure risk.
Remember: Fentanyl patch disposal: take-back first; if unavailable, fold sticky sides together and flush.
Sources:
- Fentanyl transdermal system patient instructions (DailyMed) — Instructions for Use, Disposing a Fentanyl Transdermal System
- FDA, Drug Disposal: FDA's Flush List for Certain Medicines — Flush list
Question 14
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.A.2 Pharmacokinetics, pharmacodynamics, or pharmacogenomics · Multiple choice
Genetic testing shows a patient starting clopidogrel after a coronary stent is a CYP2C19 poor metabolizer. What does this mean for clopidogrel therapy?
Reveal answer and explanation for question 14
Correct answer: C. Clopidogrel is a prodrug that relies on CYP2C19 to form its active metabolite. Its boxed warning states that poor metabolizers form less active metabolite, have a diminished antiplatelet effect, and prescribers should consider another platelet P2Y12 inhibitor.
Why the other options are wrong:
- A: Poor metabolizers form less, not more, active metabolite.
- B: Clopidogrel is a prodrug; that is why CYP2C19 matters.
- D: No labeled twice-daily regimen compensates for poor metabolism.
Remember: Clopidogrel + CYP2C19 poor metabolizer → weaker effect → consider prasugrel or ticagrelor.
Source: Plavix (clopidogrel) prescribing information (DailyMed) — Boxed Warning: Diminished antiplatelet effect in CYP2C19 poor metabolizers
Question 15
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.1 Signs, symptoms, and findings of medical conditions · Multiple response
A patient taking sertraline is started on linezolid. Six hours later he is agitated and sweating, with a temperature of 38.9 °C. Which additional findings are consistent with serotonin syndrome? (Select ALL that apply.)
Reveal answer and explanation for question 15
Correct answer: B, C, D. Serotonin syndrome develops quickly (often within hours) after a serotonergic drug is added. Linezolid is a weak MAO inhibitor. Neuromuscular hyperactivity such as clonus, hyperreflexia, and tremor, along with agitation, diaphoresis, and hyperthermia, are the hallmark findings (the Hunter criteria focus on clonus).
Why the other options are wrong:
- A: Bradycardia with pinpoint pupils suggests opioid or cholinergic toxicity; serotonin syndrome typically causes tachycardia and dilated pupils.
- E: Lead-pipe rigidity with slow onset and reduced reflexes points to neuroleptic malignant syndrome.
Remember: Serotonin syndrome: fast onset, clonus and hyperreflexia. NMS: slow onset, rigidity, low reflexes.
Source: Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120 — Clinical findings and Hunter criteria
Question 16
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.3 Rates of administration · Fill in the blank
Vancomycin 1,500 mg in 300 mL of 0.9% sodium chloride is to be infused over 90 minutes. At what rate should the pump be set?
Your answer: ______ mL/h
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 16
Correct answer: 200 mL/h. 90 minutes = 1.5 hours. 300 mL ÷ 1.5 h = 200 mL/h.
Remember: Convert minutes to hours before dividing volume by time.
Source: Worked calculation from the values in the question.
Question 17
Domain 2: Medication Use Process · 2.C.2 Immunizations: contraindications and precautions · Multiple choice
A patient who is 10 weeks pregnant has a nonimmune rubella result and asks for the measles, mumps, and rubella (MMR) vaccine today. What is the best response?
Reveal answer and explanation for question 17
Correct answer: A. MMR is a live attenuated vaccine, and its labeling lists pregnancy as a contraindication. A nonimmune pregnant patient should be vaccinated after delivery.
Why the other options are wrong:
- B: The risk of rubella does not override the contraindication to a live vaccine in pregnancy.
- C: There is no reduced-dose MMR regimen.
- D: Immune globulin does not make a live vaccine safe in pregnancy.
Remember: Live vaccines (MMR, varicella) are contraindicated in pregnancy.
Source: M-M-R II prescribing information (DailyMed) — Section 4, Contraindications
Question 18
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.6 Toxicologic exposures and overdoses · Multiple response
Which toxin-antidote pairings are correct? (Select ALL that apply.)
Reveal answer and explanation for question 18
Correct answer: B, D, E. Acetylcysteine replenishes glutathione to prevent acetaminophen liver injury. Idarucizumab is a monoclonal antibody fragment that binds dabigatran. Protamine neutralizes heparin.
Why the other options are wrong:
- A: Flumazenil reverses benzodiazepines. The opioid antidote is naloxone.
- C: Vitamin K reverses warfarin, not factor Xa inhibitors. Andexanet alfa is labeled for apixaban and rivaroxaban reversal.
Remember: APAP-acetylcysteine · dabigatran-idarucizumab · heparin-protamine · warfarin-vitamin K · opioid-naloxone · benzo-flumazenil.
Sources:
- Acetadote (acetylcysteine) prescribing information — Section 1
- Praxbind (idarucizumab) prescribing information — Section 1
- Protamine sulfate prescribing information — Section 1
- Andexxa prescribing information — Section 1
Question 19
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.D Drug development processes · Multiple choice
Which statement best describes an FDA Emergency Use Authorization (EUA)?
Reveal answer and explanation for question 19
Correct answer: B. Under an EUA, FDA may allow unapproved medical products, or unapproved uses of approved products, to be used during a declared emergency when legal criteria are met, including that known and potential benefits outweigh known and potential risks and there are no adequate, approved, available alternatives. It is not approval.
Why the other options are wrong:
- A: An EUA is not an approval; the product may later seek approval separately.
- C: Human trials require an Investigational New Drug (IND) application, not an EUA.
- D: EUAs have covered drugs, diagnostic tests, and devices, not only vaccines.
Remember: EUA ≠ approval. It is emergency permission tied to a declaration.
Source: FDA, Emergency Use Authorization — Overview
Question 20
Domain 2: Medication Use Process · 2.A.2 Indications, usage, and dosing regimens · Multiple choice
A new prescription for a patient with rheumatoid arthritis reads: methotrexate 2.5 mg tablets, take 3 tablets by mouth daily. What should the pharmacist do?
Reveal answer and explanation for question 20
Correct answer: B. For rheumatoid arthritis, oral methotrexate is taken once weekly. Methotrexate labeling warns that serious toxic reactions, including death, have occurred when weekly regimens were taken daily by mistake. A 'daily' order needs clarification before dispensing.
Why the other options are wrong:
- A: Filling a probable daily-dosing error exposes the patient to fatal toxicity.
- C: Limiting the supply still allows daily overdosing.
- D: Leucovorin is a rescue agent, not a substitute for methotrexate.
Remember: Methotrexate for RA or psoriasis: once WEEKLY. A 'daily' order is a red flag.
Source: Methotrexate tablets prescribing information (DailyMed) — Boxed Warning; Section 2, Dosage
Question 21
Domain 3: Person-Centered Assessment and Treatment Planning · 3.A Medication history, allergy history, and reconciliation · Fill in the blank
During a medication history, a patient reports taking hydrocodone/acetaminophen 5 mg/325 mg, 2 tablets every 6 hours around the clock, plus OTC acetaminophen extra strength 500 mg, 2 tablets three times daily. How many milligrams of acetaminophen is the patient taking per day?
Your answer: ______ mg
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 21
Correct answer: 5600 mg. Prescription product: 2 tablets × 4 doses = 8 tablets × 325 mg = 2,600 mg. OTC product: 2 tablets × 3 doses = 6 tablets × 500 mg = 3,000 mg. Total = 5,600 mg/day, which exceeds the 4,000 mg/day maximum in the combination product's labeling. This duplication should be resolved with the patient and prescriber.
Remember: Always add up acetaminophen from every prescription and OTC source.
Source: Hydrocodone bitartrate and acetaminophen tablets prescribing information (DailyMed) — Section 2 and hepatotoxicity warning
Question 22
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.5 Adverse drug reactions · Multiple choice
Three weeks after starting lisinopril, a patient reports a persistent dry, nonproductive cough. She has no swelling of the lips, tongue, or face. What is the most appropriate recommendation?
Reveal answer and explanation for question 22
Correct answer: D. Dry cough is a known ACE inhibitor effect caused by bradykinin accumulation. It is a class effect, so another ACE inhibitor usually won't help. ARBs don't block bradykinin breakdown, so switching to an ARB is the usual fix.
Why the other options are wrong:
- A: Suppressing the cough treats the symptom while keeping its cause.
- B: The cough is a class effect of ACE inhibitors.
- C: Same problem as A: the cause continues.
Remember: ACE inhibitor cough → switch to an ARB. ACE inhibitor angioedema → avoid ACE inhibitors.
Sources:
- Lisinopril tablets prescribing information (DailyMed) — Section 6, Adverse Reactions (cough)
- 2025 AHA/ACC High Blood Pressure Guideline — Pharmacologic treatment, drug-class considerations
Question 23
Domain 4: Professional Practice · 4.A Adverse drug event reporting and medication error reporting · Multiple choice
Two days after receiving a vaccine at your pharmacy, a patient develops a rash that he believes is related to the vaccine. Which national system is designed to receive this report?
Reveal answer and explanation for question 23
Correct answer: A. VAERS, co-managed by CDC and FDA, collects reports of adverse events after vaccination. Anyone can report, and a report does not have to prove the vaccine caused the event.
Why the other options are wrong:
- B: MedWatch covers drugs, biologics other than vaccines, and devices.
- C: The ISMP program collects medication errors, not vaccine adverse events.
- D: Boards regulate practice; they don't run national vaccine safety surveillance.
Remember: Vaccines → VAERS. Drugs and devices → MedWatch. Errors → ISMP MERP.
Sources:
- VAERS — About VAERS
- FDA MedWatch — Overview
Question 24
Domain 2: Medication Use Process · 2.A.3 Available dosage forms · Multiple response
Which nitroglycerin dosage forms are labeled for the acute relief of an attack of angina pectoris? (Select ALL that apply.)
Reveal answer and explanation for question 24
Correct answer: C, D. Sublingual tablets and translingual spray act within minutes and are labeled for acute relief of angina, as well as for prevention just before activities that trigger it.
Why the other options are wrong:
- A: Patches are labeled for prevention of angina; their onset is too slow for an acute attack.
- B: Extended-release capsules are for prevention, not acute relief.
- E: Ointment is used for prevention, not acute relief.
Remember: Acute angina: SL tablet or spray. Patch, ointment, ER capsule: prevention only.
Sources:
Question 25
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.F Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources · Multiple choice
A pharmacist needs to confirm whether a generic tablet is rated therapeutically equivalent (for example, AB-rated) to its brand. Which resource should be used?
Reveal answer and explanation for question 25
Correct answer: A. FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, the Orange Book, publishes therapeutic equivalence codes such as AB for small-molecule drug products.
Why the other options are wrong:
- B: The Purple Book covers licensed biological products, including biosimilars and interchangeables.
- C: Red Book is a drug pricing reference.
- D: The Pink Book is CDC's vaccine-preventable diseases reference.
Remember: Orange = generic equivalence. Purple = biologics. Pink = vaccines.
Source: FDA, Orange Book — Preface: therapeutic equivalence codes
Case B (Questions 26–27)
LM is a 74-year-old woman with nonvalvular atrial fibrillation who takes warfarin 5 mg daily. Her INR today is 2.4. Her urine culture shows a urinary tract infection, and her prescriber has sent a new prescription for trimethoprim-sulfamethoxazole DS, 1 tablet BID for 3 days.
Question 26
Domain 3: Person-Centered Assessment and Treatment Planning · 3.D.3 Monitoring: effectiveness · Multiple choice
Refer to Case B. What is the target INR range for LM's warfarin therapy?
Reveal answer and explanation for question 26
Correct answer: C. For nonvalvular atrial fibrillation, warfarin labeling targets an INR of 2.0 to 3.0 (goal 2.5). LM's INR of 2.4 is in range today.
Why the other options are wrong:
- A: Below the labeled range; stroke protection is reduced.
- B: 2.5 to 3.5 is used for certain mechanical heart valves, not nonvalvular AF.
- D: Above the labeled range for any common indication; bleeding risk rises.
Remember: Warfarin INR 2-3 for AF and VTE.
Source: Warfarin sodium tablets prescribing information (DailyMed) — Section 2, Dosage and Administration
Question 27
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.3 Interactions · Multiple choice
Refer to Case B. What is the most appropriate pharmacist action regarding the new trimethoprim-sulfamethoxazole prescription?
Reveal answer and explanation for question 27
Correct answer: A. Sulfamethoxazole inhibits CYP2C9, the main pathway for the more potent S-warfarin, and warfarin labeling lists it among drugs that can increase warfarin's effect. The INR can rise within days, so the prescriber should consider a noninteracting antibiotic or plan an INR check during the course.
Why the other options are wrong:
- B: This is a well-documented interaction that raises bleeding risk.
- C: The interaction is metabolic, so dose spacing doesn't prevent it.
- D: Increasing warfarin would push the INR even higher.
Remember: TMP-SMX, fluconazole, metronidazole, and amiodarone all raise warfarin's effect.
Source: Warfarin sodium tablets prescribing information (DailyMed) — Section 7, Drug Interactions (CYP2C9 inhibitors; antibiotics)
Question 28
Domain 2: Medication Use Process · 2.B Therapeutic substitutions · Multiple choice
What does an FDA 'interchangeable' designation add to a biosimilar product?
Reveal answer and explanation for question 28
Correct answer: A. Every biosimilar has been shown to have no clinically meaningful differences from its reference product. An interchangeable biosimilar meets additional requirements, so it may be substituted at the pharmacy without the prescriber's involvement, as state pharmacy laws allow.
Why the other options are wrong:
- B: Biologics don't have generics; biosimilars follow a different pathway.
- C: True of ALL biosimilars, so it isn't what interchangeability adds.
- D: The reference product is the original biologic the biosimilar is compared with.
Remember: Biosimilar = highly similar, no meaningful differences. Interchangeable = pharmacy-level substitution allowed (state law).
Source: FDA, Biosimilar and Interchangeable Biologics: More Treatment Choices — Interchangeable products
Question 29
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.1 Patient parameters or laboratory measures · Fill in the blank
Using the Devine formula, calculate the ideal body weight of a man who is 5 feet 10 inches tall.
Your answer: ______ kg
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 29
Correct answer: 73 kg. Devine IBW for males = 50 kg + 2.3 kg for each inch over 5 feet. 5 ft 10 in is 10 inches over 5 feet: 50 + (2.3 × 10) = 73 kg.
Remember: IBW: male 50 kg, female 45.5 kg, plus 2.3 kg per inch over 5 feet.
Source: Pai MP, Paloucek FP. The origin of the 'ideal' body weight equations. Ann Pharmacother. 2000 — Devine equation
Question 30
Domain 3: Person-Centered Assessment and Treatment Planning · 3.E.2 Medication use, storage, and disposal · Multiple choice
Which counseling instruction is correct for a patient starting alendronate 70 mg once weekly for osteoporosis?
Reveal answer and explanation for question 30
Correct answer: D. Alendronate is poorly absorbed and can irritate the esophagus. Labeling directs patients to take it on arising with a full glass of plain water, wait at least 30 minutes before food, other drinks, or medicines, and not lie down for at least 30 minutes.
Why the other options are wrong:
- A: Taking it at bedtime or lying down raises esophageal injury risk, and food blocks absorption.
- B: Coffee and juice reduce absorption; only plain water is allowed.
- C: Calcium binds alendronate; take calcium later in the day.
Remember: Alendronate: morning, plain water, upright 30 minutes, nothing else for 30 minutes.
Source: Fosamax (alendronate) prescribing information (DailyMed) — Section 2, Important Administration Instructions
Question 31
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.B.2 Sterile preparations · Multiple choice
A 10-day-old neonate is receiving calcium-containing IV fluids. The team orders IV ceftriaxone for suspected infection. What should the pharmacist recommend?
Reveal answer and explanation for question 31
Correct answer: D. Ceftriaxone labeling contraindicates its use in neonates 28 days old or younger who require, or are expected to require, calcium-containing IV solutions, because of fatal ceftriaxone-calcium precipitates in the lungs and kidneys. Changing lines, flushing, or route does not remove the contraindication in this age group.
Why the other options are wrong:
- A: Precipitates have occurred even with separate lines and times in neonates.
- B: Flushing is an option for patients older than 28 days, not neonates.
- C: The contraindication is not limited to the IV route.
Remember: Ceftriaxone + IV calcium in a neonate ≤28 days = contraindicated.
Source: Ceftriaxone for injection prescribing information (DailyMed) — Section 4, Contraindications; Warnings on calcium interaction
Question 32
Domain 3: Person-Centered Assessment and Treatment Planning · 3.F Over-the-counter medications and dietary supplements · Multiple choice
A patient with high blood pressure asks for a cold product to relieve nasal congestion. Which OTC active ingredient carries Drug Facts labeling telling people with high blood pressure to ask a doctor before use?
Reveal answer and explanation for question 32
Correct answer: B. Oral nasal decongestants such as pseudoephedrine can raise blood pressure. Federal OTC labeling for these products tells consumers with high blood pressure, heart disease, thyroid disease, diabetes, or trouble urinating from an enlarged prostate to ask a doctor before use.
Why the other options are wrong:
- A: Saline spray has no systemic cardiovascular effect.
- C: Single-ingredient loratadine is an antihistamine without a decongestant. 'D' combination versions do contain pseudoephedrine.
- D: Guaifenesin is an expectorant without that warning.
Remember: Check the 'D' on combination products: it usually means pseudoephedrine.
Source: Pseudoephedrine hydrochloride OTC Drug Facts label (DailyMed) — Drug Facts: Warnings, Ask a doctor before use
Question 33
Domain 2: Medication Use Process · 2.C.3 Immunizations: storage and handling · Multiple choice
Which vaccine's labeling directs that it be stored frozen?
Reveal answer and explanation for question 33
Correct answer: D. Varivax labeling directs freezer storage (−50 °C to −15 °C). It may be kept in a refrigerator only for a limited time stated in the label, and then must be used or discarded.
Why the other options are wrong:
- A: Shingrix is refrigerated, not frozen.
- B: Tdap is refrigerated and must not be frozen.
- C: Inactivated influenza vaccines are refrigerated and must not be frozen.
Remember: Varivax: freezer. Most inactivated vaccines: refrigerator, never frozen.
Source: Varivax prescribing information (DailyMed) — Section 16, How Supplied/Storage and Handling
Question 34
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.7 Adherence · Fill in the blank
Over a 120-day measurement period, a patient filled 30-day supplies of an antihypertensive on day 1, day 41, and day 95. Assuming each fill covers consecutive days from its fill date, what is the proportion of days covered (PDC)?
Your answer: ______ %
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 34
Correct answer: 72 %. Covered days: day 1-30 (30 days) + day 41-70 (30 days) + day 95-120 (26 days, because the period ends on day 120) = 86 days. PDC = 86 ÷ 120 = 71.7%, which rounds to 72%. That is below the 80% threshold commonly used in adherence quality measures.
Remember: PDC counts covered days in the window; supply that runs past the window's end doesn't count.
Source: Pharmacy Quality Alliance, adherence measures — Proportion of days covered
Question 35
Domain 5: Pharmacy Management and Leadership · 5.B Inventory and supply management · Multiple choice
A pharmacy buyer wants to confirm whether an injectable antibiotic is in a national shortage and see the reported reason and expected duration. Which official U.S. source is designed for this?
Reveal answer and explanation for question 35
Correct answer: D. FDA's Drug Shortages Database lists current and resolved shortages, often with the reason and estimated resolution information supplied by manufacturers.
Why the other options are wrong:
- A: The Orange Book covers approvals and therapeutic equivalence, not supply status.
- B: The NDC Directory lists product identifiers, not shortage status.
- C: A representative can add detail but isn't the official national record.
Remember: Shortages: FDA Drug Shortages Database (ASHP also tracks shortages).
Source: FDA Drug Shortages Database — Current and resolved shortages
Question 36
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.A.3 Pharmaceutics · Multiple choice
A patient with dysphagia asks whether her tablets can be crushed. Which of these should NOT be crushed?
Reveal answer and explanation for question 36
Correct answer: C. Extended-release nifedipine tablets are designed to release drug slowly. Labeling says to swallow them whole, not chew, divide, or crush, because crushing can release the full dose at once and cause profound hypotension.
Why the other options are wrong:
- A: Immediate-release lisinopril has no release-controlling design.
- B: Amlodipine is an immediate-release tablet.
- D: Metoprolol tartrate immediate-release is not a controlled-release product (metoprolol succinate ER is).
Remember: ER, XL, SR, CR, and enteric-coated products are the usual do-not-crush suspects.
Source: Procardia XL (nifedipine extended-release) prescribing information (DailyMed) — Section 2, Dosage and Administration
Question 37
Domain 3: Person-Centered Assessment and Treatment Planning · 3.D.1 Therapeutic goals, clinical endpoints, and follow-up · Multiple choice
According to the ADA Standards of Care, what is the general A1C goal for many nonpregnant adults with diabetes when it can be reached without significant hypoglycemia?
Reveal answer and explanation for question 37
Correct answer: B. The ADA sets an A1C goal of less than 7% for many nonpregnant adults without significant hypoglycemia, with more or less stringent goals individualized to the patient.
Why the other options are wrong:
- A: 5.7% is the prediabetes cutoff, not a treatment goal.
- C: A universal <6.0% goal would raise hypoglycemia risk.
- D: Less stringent goals are for selected patients, not everyone.
Remember: Default A1C goal: <7%, individualized.
Source: ADA Standards of Care in Diabetes—2026 — Section 6, Glycemic Goals
Question 38
Domain 4: Professional Practice · 4.D Ethical considerations · Multiple choice
A caller who says she is a patient's employer asks the pharmacy which medications the patient is taking. The patient has not authorized any disclosure. What should the pharmacist do?
Reveal answer and explanation for question 38
Correct answer: C. Under the HIPAA Privacy Rule, a pharmacy may not disclose protected health information to an employer for employment purposes without the patient's authorization. Knowing identifying details does not make the caller authorized.
Why the other options are wrong:
- A: Paying for coverage does not give the employer access to a patient's records.
- B: No exception exists for controlled substances in this situation.
- D: Knowing a date of birth doesn't grant access.
Remember: Employer requests → no disclosure without the patient's authorization.
Source: HHS, Summary of the HIPAA Privacy Rule — Uses and disclosures; authorization
Question 39
Domain 2: Medication Use Process · 2.C.5 Immunizations: adverse reactions · Multiple choice
A 16-year-old becomes pale and lightheaded right after an intramuscular vaccine in your pharmacy. There is no rash, wheezing, or throat swelling. What is the most appropriate action?
Reveal answer and explanation for question 39
Correct answer: C. This looks like a vasovagal (fainting) reaction, which is common after injections, especially in adolescents. CDC advises having patients seated or lying down and considering 15 minutes of observation after vaccination; if syncope develops, observe until symptoms resolve.
Why the other options are wrong:
- A: Epinephrine is for anaphylaxis; she has no signs of it.
- B: Standing increases the risk of falling and injury.
- D: She should not leave or drive until she has recovered.
Remember: Fainting: sit or lie down and observe. Anaphylaxis signs: give epinephrine IM.
Source: CDC, General Best Practice Guidelines: Preventing and Managing Adverse Reactions — Syncope
Question 40
Domain 5: Pharmacy Management and Leadership · 5.C Quality improvement activities · Multiple choice
Before launching a new automated dispensing cabinet workflow, a hospital pharmacy team wants to identify how the new process could fail and which failures would cause the most harm. Which tool fits best?
Reveal answer and explanation for question 40
Correct answer: D. FMEA is a proactive tool. The team maps a process, lists ways each step could fail, and ranks failures by severity and likelihood before harm occurs.
Why the other options are wrong:
- A: Root cause analysis looks back at an event that has already happened.
- B: A medication use evaluation reviews how a drug is being used against criteria.
- C: A Pareto chart ranks past problems; it doesn't analyze a process that hasn't started.
Remember: FMEA = before (prospective). RCA = after (retrospective).
Source: IHI, Failure Modes and Effects Analysis (FMEA) Tool — Tool overview
Question 41
Domain 3: Person-Centered Assessment and Treatment Planning · 3.G Devices to administer medications and self-monitoring tests · Multiple choice
A patient is starting an insulin lispro prefilled pen (Humalog KwikPen). What should she do with a new pen needle attached, before each injection?
Reveal answer and explanation for question 41
Correct answer: A. The pen's Instructions for Use tell patients to prime before each injection: dial 2 units, hold the pen needle-up, tap out air bubbles, and push until insulin appears. Priming removes air and confirms the pen and needle work.
Why the other options are wrong:
- B: Shaking is not a preparation step for this clear insulin; priming is.
- C: Priming is needed before every injection, including the first.
- D: Pens are not handled like vials; injecting air is not a pen step.
Remember: Pen routine: new needle, prime 2 units, inject, hold, remove needle.
Source: Humalog KwikPen Instructions for Use (DailyMed) — Instructions for Use, Priming
Question 42
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.6 Quantities of drugs or ingredients to be compounded · Fill in the blank
How many grams of hydrocortisone powder are needed to compound 60 g of a 2.5% (w/w) hydrocortisone cream?
Your answer: ______ g
Round the final answer to ONE decimal place. Answer must be numeric.
Reveal answer and explanation for question 42
Correct answer: 1.5 g. 2.5% w/w means 2.5 g per 100 g. 60 g × 0.025 = 1.5 g.
Remember: % w/w = grams of ingredient per 100 g of product.
Source: Worked calculation from the values in the question.
Question 43
Domain 2: Medication Use Process · 2.A.4 Prescription regulations · Multiple choice
Which drug class carries a boxed warning about increased risk of suicidal thoughts and behaviors in pediatric and young adult patients?
Reveal answer and explanation for question 43
Correct answer: D. Antidepressants such as sertraline carry a boxed warning that they increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Patients should be monitored for worsening mood and emergence of suicidal thoughts.
Why the other options are wrong:
- A: Statins have no such boxed warning.
- B: PPIs have no boxed warning.
- C: ARBs carry a boxed warning for fetal toxicity, not suicidality.
Remember: Antidepressant box: suicidality in children, adolescents, and young adults.
Source: Sertraline tablets prescribing information (DailyMed) — Boxed Warning
Question 44
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.2 Appropriateness of therapy · Multiple choice
A 78-year-old man asks for diphenhydramine to help him sleep. He has benign prostatic hyperplasia. What is the best response?
Reveal answer and explanation for question 44
Correct answer: D. The AGS Beers Criteria list first-generation antihistamines such as diphenhydramine as potentially inappropriate for older adults because they are highly anticholinergic. Risks include confusion, constipation, and urinary retention, which is a special concern with BPH.
Why the other options are wrong:
- A: Recommending the drug ignores the Beers Criteria and his BPH.
- B: A higher dose adds anticholinergic burden.
- C: Doxylamine is also a strongly anticholinergic first-generation antihistamine.
Remember: Older adults: avoid first-generation antihistamines (diphenhydramine, doxylamine, hydroxyzine).
Source: American Geriatrics Society 2023 Updated AGS Beers Criteria — Table 2, first-generation antihistamines
Question 45
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.A.1 Pharmacology · Multiple response
Warfarin inhibits vitamin K epoxide reductase and reduces synthesis of which clotting factors? (Select ALL that apply.)
Reveal answer and explanation for question 45
Correct answer: A, B, C, D. Warfarin blocks regeneration of reduced vitamin K, which the liver needs to activate factors II, VII, IX, and X (and the anticoagulant proteins C and S).
Why the other options are wrong:
- E: Factor XII is not vitamin K-dependent.
- F: Factor VIII is not vitamin K-dependent.
Remember: Vitamin K-dependent factors: 2, 7, 9, 10 (plus proteins C and S).
Source: Warfarin sodium tablets prescribing information (DailyMed) — Section 12.1, Mechanism of Action
Question 46
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.2 Appropriateness of therapy · Multiple choice
An adult with asthma has symptoms about twice a month and uses only albuterol as needed. According to GINA, what is the preferred treatment (Track 1)?
Reveal answer and explanation for question 46
Correct answer: B. GINA no longer recommends SABA-only treatment for adults and adolescents. Its preferred Track 1 approach for mild asthma is as-needed low-dose ICS-formoterol, which cuts severe exacerbation risk compared with SABA alone.
Why the other options are wrong:
- A: SABA-only treatment is linked with higher exacerbation risk and is not recommended.
- C: LABA monotherapy without an inhaled corticosteroid is unsafe in asthma.
- D: Montelukast is a less effective alternative, not the preferred option.
Remember: GINA: no SABA-only treatment in adults; ICS-formoterol as reliever is preferred.
Source: GINA 2026 Strategy Report — Track 1, Steps 1–2 treatment for adults and adolescents
Question 47
Domain 2: Medication Use Process · 2.A.2 Indications, usage, and dosing regimens · Multiple choice
An 82-year-old woman who weighs 58 kg and has a serum creatinine of 1.0 mg/dL starts apixaban for nonvalvular atrial fibrillation. She takes no interacting drugs. What is the appropriate dose?
Reveal answer and explanation for question 47
Correct answer: B. For nonvalvular AF, apixaban labeling recommends 5 mg twice daily unless the patient has at least two of: age ≥80 years, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL. She meets two (age and weight), so the dose is 2.5 mg twice daily.
Why the other options are wrong:
- A: The standard dose applies when fewer than two criteria are met.
- C: The 10 mg lead-in is for treating acute VTE, not AF.
- D: Apixaban is dosed twice daily for AF.
Remember: Apixaban AF dose reduction: 2 of 3 (age ≥80, weight ≤60 kg, SCr ≥1.5).
Source: Eliquis (apixaban) prescribing information (DailyMed) — Section 2, Dosage and Administration
Question 48
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.5 Drug concentrations, ratio strengths, osmolarity, or osmolality · Fill in the blank
How many grams of a 10% ointment must be mixed with a 2% ointment to prepare 100 g of a 5% ointment?
Your answer: ______ g
Round the final answer to ONE decimal place. Answer must be numeric.
Reveal answer and explanation for question 48
Correct answer: 37.5 g. Alligation: the 10% ointment contributes 5 − 2 = 3 parts and the 2% ointment 10 − 5 = 5 parts, 8 parts total. 3/8 × 100 g = 37.5 g of the 10% ointment (and 62.5 g of the 2%). Check: (37.5 × 0.10 + 62.5 × 0.02) ÷ 100 = 5%.
Remember: Alligation: each strength's parts equal the distance of the OTHER strength from the target.
Source: Worked calculation from the values in the question.
Question 49
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.2 Appropriateness of therapy · Multiple choice
A 29-year-old patient who takes lisinopril 10 mg daily for hypertension tells you she just learned she is pregnant. What is the most appropriate recommendation?
Reveal answer and explanation for question 49
Correct answer: A. ACE inhibitors carry a boxed warning for fetal toxicity: drugs acting on the renin-angiotensin system can injure and kill the developing fetus. Labeling says to discontinue as soon as possible when pregnancy is detected, so the prescriber needs to choose an alternative.
Why the other options are wrong:
- B: Lisinopril is not safe in pregnancy.
- C: Any dose carries the fetal risk.
- D: ARBs such as losartan carry the same fetal toxicity boxed warning.
Remember: ACE inhibitors, ARBs, and aliskiren: stop when pregnancy is detected.
Source: Lisinopril tablets prescribing information (DailyMed) — Boxed Warning: Fetal Toxicity
Question 50
Domain 2: Medication Use Process · 2.A.3 Available dosage forms · Multiple response
Which of these drugs are available in the United States as a transdermal system (patch)? (Select ALL that apply.)
Reveal answer and explanation for question 50
Correct answer: B, C, E. Rivastigmine (for dementia), clonidine (for hypertension), and fentanyl (for opioid-tolerant chronic pain) all come as transdermal systems.
Why the other options are wrong:
- A: Amlodipine is oral only.
- D: Metoprolol is available orally and IV, not as a patch.
Remember: Know common patches: rivastigmine, clonidine, fentanyl, buprenorphine, nitroglycerin, scopolamine, estradiol, rotigotine.
Sources:
Question 51
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.3 Interactions · Multiple choice
A patient taking phenelzine for depression asks whether she can eat aged cheddar and cured salami at a party. What is the main risk?
Reveal answer and explanation for question 51
Correct answer: D. Phenelzine is a monoamine oxidase inhibitor (MAOI). With MAO blocked, tyramine from aged, fermented, or cured foods isn't broken down and can trigger a dangerous release of norepinephrine and a hypertensive crisis. MAOI labeling tells patients to avoid high-tyramine foods.
Why the other options are wrong:
- A: Serotonin syndrome is a risk with serotonergic drugs, not tyramine-rich food.
- B: Tyramine does not cause hypoglycemia.
- C: The concern is a pharmacodynamic reaction, not absorption.
Remember: MAOI + tyramine (aged cheese, cured meats, tap beer, soy sauce) = hypertensive crisis.
Source: Nardil (phenelzine) prescribing information (DailyMed) — Warnings: hypertensive crises; dietary restrictions
Question 52
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.D Drug development processes · Multiple choice
A sponsor wants to begin the first clinical trial of a new molecule in humans in the United States. Which application must be in effect first?
Reveal answer and explanation for question 52
Correct answer: D. Under FDA regulations (21 CFR 312), a sponsor must have an IND in effect before giving an investigational drug to humans in a clinical investigation. The NDA, ANDA, and BLA are marketing applications submitted later.
Why the other options are wrong:
- A: An NDA seeks marketing approval after clinical studies.
- B: An ANDA is for generic drug approval.
- C: A BLA seeks licensure to market a biologic.
Remember: IND = permission to study in humans. NDA/BLA = permission to market. ANDA = generics.
Source: FDA, Investigational New Drug (IND) Application — Overview
Question 53
Domain 2: Medication Use Process · 2.A.5 Safety and effectiveness · Multiple choice
A patient with chronic kidney disease brings in a new prescription for spironolactone. Which laboratory value is most important to check before dispensing?
Reveal answer and explanation for question 53
Correct answer: D. Spironolactone is a potassium-sparing aldosterone antagonist. Its labeling warns of hyperkalemia, especially with impaired kidney function, and advises checking potassium before starting and periodically after.
Why the other options are wrong:
- A: Sodium can change but isn't the key safety value here.
- B: A1C isn't related to spironolactone's main risk.
- C: Cholesterol isn't related to spironolactone's main risk.
Remember: Spironolactone, eplerenone, ACE inhibitors, ARBs: watch potassium and kidney function.
Source: Spironolactone tablets prescribing information (DailyMed) — Section 5, Hyperkalemia
Question 54
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.3 Interactions · Multiple choice
A patient who takes a high-dose biotin supplement for hair and nails comes to the emergency department with chest pain. Why should the team know about the biotin?
Reveal answer and explanation for question 54
Correct answer: C. FDA has warned that biotin can interfere with lab tests that use biotin-streptavidin technology, causing falsely high or falsely low results. A falsely low troponin could lead to a missed heart attack.
Why the other options are wrong:
- A: Biotin is not known to cause vasospasm.
- B: Biotin doesn't alter coagulation.
- D: Biotin doesn't raise potassium.
Remember: Ask about biotin when immunoassay results (troponin, thyroid tests) don't fit the clinical picture.
Source: FDA Safety Communication: Biotin may interfere with lab tests (updated 2019) — Summary
Question 55
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.5 Drug concentrations, ratio strengths, osmolarity, or osmolality · Fill in the blank
How many milliequivalents of potassium are in 10 mL of a 14.9% (w/v) potassium chloride injection? (Molecular weight of KCl = 74.55 g/mol.)
Your answer: ______ mEq
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 55
Correct answer: 20 mEq. 14.9% w/v = 14.9 g per 100 mL, so 10 mL contains 1.49 g KCl. 1.49 g ÷ 74.55 g/mol = 0.01999 mol = 19.99 mmol. KCl has a valence of 1, so mmol = mEq: about 20 mEq.
Remember: mEq = (mg ÷ molecular weight) × valence.
Source: Worked calculation from the values in the question.
Question 56
Domain 4: Professional Practice · 4.B Public health initiatives and risk-prevention programs · Multiple choice
In the U.S. Public Health Service '5 A's' model for tobacco cessation, what does the 'Arrange' step mean?
Reveal answer and explanation for question 56
Correct answer: B. The 5 A's are Ask, Advise, Assess, Assist, and Arrange. 'Arrange' means scheduling follow-up, preferably soon after the quit date, to support the attempt and address relapse.
Why the other options are wrong:
- A: This has nothing to do with the 5 A's.
- C: Brief interventions start with the clinician, not an automatic referral.
- D: Reduction plans aren't what 'Arrange' refers to.
Remember: Ask · Advise · Assess · Assist · Arrange (follow-up).
Source: Treating Tobacco Use and Dependence: 2008 Update (USPHS Clinical Practice Guideline, NCBI Bookshelf) — The 5 A's
Question 57
Domain 2: Medication Use Process · 2.A.1 Drug names and therapeutic classes · Multiple choice
Which drug is a dipeptidyl peptidase-4 (DPP-4) inhibitor?
Reveal answer and explanation for question 57
Correct answer: B. Sitagliptin blocks DPP-4, the enzyme that breaks down incretin hormones, which raises GLP-1 and GIP levels. The '-gliptin' ending marks DPP-4 inhibitors.
Why the other options are wrong:
- A: Semaglutide is a GLP-1 receptor agonist ('-glutide').
- C: Canagliflozin is an SGLT2 inhibitor ('-gliflozin').
- D: Pioglitazone is a thiazolidinedione ('-glitazone').
Remember: -gliptin DPP-4 · -glutide GLP-1 RA · -gliflozin SGLT2 · -glitazone TZD.
Source: Januvia (sitagliptin) prescribing information (DailyMed) — Section 12.1
Question 58
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.3 Interactions · Multiple choice
A man who takes isosorbide mononitrate for chronic angina presents a new prescription for sildenafil for erectile dysfunction. What should the pharmacist do?
Reveal answer and explanation for question 58
Correct answer: D. Sildenafil labeling contraindicates use with any nitrate, taken regularly or as needed, because the combination can cause profound, potentially fatal hypotension.
Why the other options are wrong:
- A: Spacing doses does not prevent the interaction with a daily long-acting nitrate.
- B: Any dose is contraindicated with nitrates.
- C: Grapefruit is a minor issue compared with the contraindication.
Remember: PDE-5 inhibitors + nitrates (including as-needed NTG) = contraindicated.
Source: Viagra (sildenafil) prescribing information (DailyMed) — Section 4, Contraindications
Question 59
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.E Research design principles and biostatistics · Multiple choice
In a randomized controlled trial, what does an intention-to-treat analysis do?
Reveal answer and explanation for question 59
Correct answer: D. Intention-to-treat keeps everyone in the group they were randomized to. That preserves the balance randomization created and gives a more realistic, conservative estimate of treatment effect.
Why the other options are wrong:
- A: That describes a completers (per-protocol-style) analysis.
- B: Excluding crossovers breaks randomization; it is a per-protocol approach.
- C: That is an as-treated analysis.
Remember: ITT: analyze as randomized. Per-protocol: analyze those who followed the protocol.
Source: Moher D, et al. CONSORT 2010 explanation and elaboration. BMJ. 2010;340:c869 — Item 16, numbers analysed
Question 60
Domain 2: Medication Use Process · 2.B Therapeutic substitutions · Multiple choice
A hospital's pharmacy and therapeutics (P&T) committee approves a policy allowing pharmacists to automatically change orders for one proton pump inhibitor to the formulary PPI at an equivalent dose. What is this called?
Reveal answer and explanation for question 60
Correct answer: B. Therapeutic interchange means substituting a chemically different drug that is expected to have similar effects, under a policy approved by the organization's P&T committee and medical staff.
Why the other options are wrong:
- A: Generic substitution swaps a brand for a product with the same active ingredient.
- C: Off-label use means using a drug for an unapproved indication.
- D: Biosimilar substitution involves biologics, not small-molecule PPIs.
Remember: Same active ingredient = generic substitution. Different drug, same class, by P&T policy = therapeutic interchange.
Source: ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System — Formulary system; therapeutic interchange
Question 61
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.4 Errors and omissions · Multiple choice
A 62-year-old man is 3 months past a myocardial infarction. His medications are aspirin, metoprolol succinate, and lisinopril. His LDL-C is 110 mg/dL, and he has no history of statin intolerance. What is the most important therapy gap?
Reveal answer and explanation for question 61
Correct answer: B. He has clinical atherosclerotic cardiovascular disease (a recent MI). The 2026 ACC/AHA multisociety dyslipidemia guideline recommends high-intensity statin therapy for adults with clinical ASCVD who are not at very high risk, aiming for at least a 50% LDL-C reduction and an LDL-C goal below 70 mg/dL; more intensive LDL-C goals apply to very-high-risk secondary prevention.
Why the other options are wrong:
- A: Moderate intensity is for patients who can't tolerate high intensity, not the first choice here.
- C: Niacin has not been shown to reduce events when added to statins.
- D: OTC fish oil is not a substitute for statin therapy.
Remember: Clinical ASCVD after MI: high-intensity statin therapy is foundational secondary prevention.
Source: 2026 ACC/AHA Multisociety Guideline on the Management of Dyslipidemia — Section 4.2.6, Secondary ASCVD Prevention
Question 62
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.7 Nutritional needs and the content of nutrient sources · Fill in the blank
How many kilocalories are provided by 500 mL of 50% dextrose injection? (Use 3.4 kcal/g for dextrose.)
Your answer: ______ kcal
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 62
Correct answer: 850 kcal. 50% dextrose = 50 g per 100 mL, so 500 mL contains 250 g. 250 g × 3.4 kcal/g = 850 kcal.
Remember: Dextrose (hydrated) = 3.4 kcal/g. Lipid 20% emulsion = 2 kcal/mL. Protein = 4 kcal/g.
Source: Dextrose 50% injection prescribing information (DailyMed) — Description: caloric content
Question 63
Domain 2: Medication Use Process · 2.C.4 Immunizations: administration · Multiple choice
By what route is recombinant zoster vaccine (Shingrix) administered?
Reveal answer and explanation for question 63
Correct answer: A. Shingrix is given as a 0.5 mL intramuscular injection, usually in the deltoid.
Why the other options are wrong:
- B: Subcutaneous is used for some live vaccines, but not Shingrix.
- C: Intradermal is not a labeled route for Shingrix.
- D: No zoster vaccine is given intranasally.
Remember: Shingrix: 0.5 mL IM, 2 doses.
Source: Shingrix prescribing information (DailyMed) — Section 2, Dosage and Administration
Question 64
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.5 Adverse drug reactions · Multiple choice
A patient who has taken phenytoin for several years has overgrown, swollen gums. Which adverse effect is this?
Reveal answer and explanation for question 64
Correct answer: B. Gingival hyperplasia is a recognized adverse effect of long-term phenytoin. Labeling recommends good oral hygiene and regular dental care to reduce it.
Why the other options are wrong:
- A: Gum overgrowth is not an allergic reaction.
- C: This is a direct drug effect, not scurvy.
- D: Toxicity typically shows as nystagmus, ataxia, and slurred speech, not gum growth.
Remember: Phenytoin: gingival hyperplasia, hirsutism, nystagmus and ataxia at high levels.
Source: Dilantin (phenytoin) prescribing information (DailyMed) — Adverse Reactions; gingival hyperplasia
Question 65
Domain 5: Pharmacy Management and Leadership · 5.C Quality improvement activities · Multiple choice
A health system reviews a sample of vancomycin orders against approved criteria for dosing, monitoring, and indication, then uses the findings to change its protocol. What is this activity?
Reveal answer and explanation for question 65
Correct answer: D. An MUE is a performance improvement method that evaluates how a medication is being used against defined criteria and then acts to improve use. It is proactive and focused on patterns of use.
Why the other options are wrong:
- A: Root cause analysis investigates a specific adverse event or error.
- B: ADE reporting documents individual events.
- C: This review is about how the drug is used, not whether to remove it.
Remember: MUE: compare real use with criteria, then fix the process.
Source: ASHP Guidelines on Medication-Use Evaluation — Definition and purpose of MUE
Question 66
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.9 Pharmacokinetic parameters · Fill in the blank
A drug follows first-order elimination with a half-life of 6 hours. What percentage of a dose remains in the body 18 hours after an IV bolus (assume no further doses)?
Your answer: ______ %
Round the final answer to ONE decimal place. Answer must be numeric.
Reveal answer and explanation for question 66
Correct answer: 12.5 %. 18 hours ÷ 6 hours = 3 half-lives. 100% → 50% → 25% → 12.5%.
Remember: Fraction remaining = (1/2)^(number of half-lives).
Source: Worked calculation from the values in the question.
Question 67
Domain 2: Medication Use Process · 2.C.5 Immunizations: adverse reactions · Multiple choice
Minutes after a vaccine, an adult develops widespread hives, wheezing, and throat tightness. What is the first-line treatment?
Reveal answer and explanation for question 67
Correct answer: A. Hives plus breathing symptoms after vaccination suggest anaphylaxis. CDC guidance says epinephrine is the first-line treatment and should be available wherever vaccines are given; emergency services should be called.
Why the other options are wrong:
- B: Antihistamines can help skin symptoms but don't treat airway or circulation compromise.
- C: Albuterol may be added but does not replace epinephrine.
- D: Delaying epinephrine in anaphylaxis is dangerous.
Remember: Anaphylaxis: epinephrine IM first, then call 911.
Source: CDC, General Best Practice Guidelines: Preventing and Managing Adverse Reactions — Managing allergic reactions
Question 68
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.5 Adverse drug reactions · Multiple choice
A patient who started metformin immediate-release 1,000 mg twice daily last week has bothersome diarrhea and nausea. Her kidney function is normal. What is the most appropriate recommendation?
Reveal answer and explanation for question 68
Correct answer: B. Gastrointestinal effects are common when metformin is started too aggressively. Immediate-release metformin labeling directs taking it with meals and starting at a lower dose with gradual titration to improve tolerability.
Why the other options are wrong:
- A: GI intolerance often improves with administration with meals and slower titration; permanent discontinuation is not automatically necessary when kidney function is normal.
- C: Immediate-release metformin should be taken with meals, not on an empty stomach.
- D: Doubling the dose would be expected to worsen GI intolerance.
Remember: Metformin IR: take with meals and titrate gradually rather than starting at a high dose.
Source: Metformin hydrochloride tablets prescribing information (DailyMed) — Section 2, Dosage and Administration
Question 69
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.E Research design principles and biostatistics · Multiple choice
Researchers compare mean systolic blood pressure (a continuous, normally distributed variable) between two independent groups of patients. Which statistical test is most appropriate?
Reveal answer and explanation for question 69
Correct answer: C. An unpaired t-test compares the means of a continuous, normally distributed variable between two independent groups.
Why the other options are wrong:
- A: Chi-square compares categorical (nominal) data, such as proportions.
- B: A paired t-test compares two measurements on the same subjects.
- D: Kaplan-Meier describes time-to-event (survival) data.
Remember: Two independent means, normal data → unpaired t-test. Proportions → chi-square.
Source: BMJ, Statistics at Square One — Chapter on the t tests
Question 70
Domain 2: Medication Use Process · 2.C.2 Immunizations: contraindications and precautions · Multiple choice
Which history is a contraindication to giving another dose of the same vaccine?
Reveal answer and explanation for question 70
Correct answer: B. A severe allergic reaction (such as anaphylaxis) after a previous dose, or to a vaccine component, is a contraindication for that vaccine in CDC guidance.
Why the other options are wrong:
- A: Local soreness and low-grade fever are expected reactions, not contraindications.
- C: Mild illness without fever is not a reason to delay vaccination.
- D: Antibiotics are not a contraindication for most vaccines.
Remember: Prior anaphylaxis to the vaccine or a component = contraindication.
Source: CDC, General Best Practice Guidelines: Contraindications and Precautions — General contraindications
Question 71
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.6 Toxicologic exposures and overdoses · Multiple choice
A patient arrives 2 hours after a single, known-time acetaminophen overdose. When should the serum acetaminophen level be drawn to plot on the treatment nomogram?
Reveal answer and explanation for question 71
Correct answer: C. The acetaminophen nomogram starts at 4 hours after ingestion because levels drawn earlier may not reflect peak absorption. Acetylcysteine labeling directs drawing the level at 4 hours or later and using the nomogram to decide on treatment.
Why the other options are wrong:
- A: Levels before 4 hours can't be interpreted on the nomogram.
- B: Waiting 12 hours delays treatment decisions; the nomogram starts at 4 hours.
- D: For a single acute ingestion with a known time, the level is central to the decision.
Remember: APAP level: at 4 hours or later, then plot on the nomogram.
Source: Acetadote (acetylcysteine) prescribing information (DailyMed) — Section 2, Dosage and Administration; nomogram
Question 72
Domain 4: Professional Practice · 4.C Social determinants and drivers of health · Multiple choice
Healthy People 2030 groups the social determinants of health into five domains. Which is one of them?
Reveal answer and explanation for question 72
Correct answer: B. Healthy People 2030's five SDOH domains are economic stability, education access and quality, health care access and quality, neighborhood and built environment, and social and community context.
Why the other options are wrong:
- A: Genetics affects health but is a biological factor, not a social determinant.
- C: Pharmacogenomics is also biological.
- D: Age is a biological and demographic factor, not an SDOH domain.
Remember: SDOH: economic, education, health care access, neighborhood, social context.
Source: Healthy People 2030, Social Determinants of Health — Five domains
Question 73
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.9 Pharmacokinetic parameters · Fill in the blank
A 70-kg patient needs an IV loading dose of a drug to reach a plasma concentration of 10 mg/L. The volume of distribution is 0.7 L/kg, and the drug is given IV as the free drug (bioavailability 1, salt factor 1). What loading dose is needed?
Your answer: ______ mg
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 73
Correct answer: 490 mg. Vd = 0.7 L/kg × 70 kg = 49 L. Loading dose = target concentration × Vd = 10 mg/L × 49 L = 490 mg.
Remember: Loading dose = Cp × Vd ÷ (F × S).
Source: Worked calculation from the values in the question.
Question 74
Domain 2: Medication Use Process · 2.D Medication handling, storage, stability, and disposal · Multiple choice
A patient asks how long she can use her insulin lispro prefilled pen (Humalog KwikPen) after its first use when it is kept at room temperature.
Reveal answer and explanation for question 74
Correct answer: B. Humalog labeling states that an in-use pen kept at room temperature (up to 86 °F / 30 °C) should be discarded 28 days after first use, even if insulin remains.
Why the other options are wrong:
- A: Too short for this product.
- C: Too short for this product; some other insulins have shorter in-use times.
- D: The printed date applies to unopened pens stored in the refrigerator.
Remember: In-use times differ by insulin product. Check each label.
Source: Humalog prescribing information (DailyMed) — Section 16, Storage and Handling
Question 75
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.6 Toxicologic exposures and overdoses · Multiple response
A family member is being taught to recognize an opioid overdose before using naloxone nasal spray. Which signs point to an opioid overdose? (Select ALL that apply.)
Reveal answer and explanation for question 75
Correct answer: A, C, E. Naloxone labeling teaches caregivers to look for the signs of opioid overdose: unusual sleepiness or unresponsiveness, breathing problems (slow or shallow breathing), and very small pupils.
Why the other options are wrong:
- B: Opioids constrict the pupils. Dilated pupils point elsewhere, for example stimulant or anticholinergic toxicity.
- D: Fever with heavy sweating is more typical of serotonin syndrome or sympathomimetic toxicity.
Remember: Opioid overdose triad: unresponsive, slow breathing, pinpoint pupils.
Source: Narcan (naloxone) nasal spray labeling (DailyMed) — Quick Start Guide / Instructions for Use
Question 76
Domain 5: Pharmacy Management and Leadership · 5.A Pharmacy operations · Multiple choice
A pharmacy is updating its shelf labels and computer display so that 'hydrOXYzine' and 'hydrALAZINE' look clearly different. What error-prevention strategy is this?
Reveal answer and explanation for question 76
Correct answer: A. Tall man lettering uses selective capital letters to highlight the parts of look-alike names that differ. ISMP publishes a list of drug name pairs for which it recommends this approach.
Why the other options are wrong:
- B: Barcode scanning is a separate technology-based safeguard.
- C: An independent double check is a second person verifying the work.
- D: Automatic stop orders end therapy after a set time.
Remember: Look-alike names: tall man lettering, separate storage, barcode scanning.
Source: ISMP, List of Confused Drug Names / Tall Man Letters — Tall man lettering list
Question 77
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.A.1 Pharmacology · Multiple choice
How does empagliflozin lower blood glucose?
Reveal answer and explanation for question 77
Correct answer: A. Empagliflozin blocks SGLT2 in the proximal tubule. That reduces glucose reabsorption and lowers the renal threshold, so more glucose is excreted in the urine.
Why the other options are wrong:
- B: That describes sulfonylureas.
- C: That describes DPP-4 inhibitors such as sitagliptin.
- D: That is the main action attributed to metformin.
Remember: SGLT2 inhibitors: glucose out in the urine (watch genital infections and volume depletion).
Source: Jardiance (empagliflozin) prescribing information (DailyMed) — Section 12.1, Mechanism of Action
Question 78
Domain 2: Medication Use Process · 2.D Medication handling, storage, stability, and disposal · Multiple choice
Which of these drugs appears on NIOSH's list of hazardous drugs in healthcare settings and needs hazardous-drug handling precautions?
Reveal answer and explanation for question 78
Correct answer: C. Methotrexate is an antineoplastic and immunosuppressant with carcinogenic, teratogenic, and other hazardous properties. It appears on the NIOSH hazardous drug list, so handling precautions apply.
Why the other options are wrong:
- A: Acetaminophen is not on the NIOSH list.
- B: Amoxicillin is not on the NIOSH list.
- D: Famotidine is not on the NIOSH list.
Remember: Many antineoplastics, some hormones, and certain teratogens are NIOSH hazardous drugs.
Source: NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 — Table 1
Question 79
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.1 Signs, symptoms, and findings of medical conditions · Multiple response
Which symptoms are consistent with hypothyroidism? (Select ALL that apply.)
Reveal answer and explanation for question 79
Correct answer: A, C, E, F. Too little thyroid hormone slows metabolism, causing fatigue, feeling cold, weight gain, constipation, dry skin, and slowed thinking.
Why the other options are wrong:
- B: Tremor points to hyperthyroidism.
- D: Heat intolerance points to hyperthyroidism.
Remember: Hypo = slow and cold. Hyper = fast and hot.
Source: NIDDK, Hypothyroidism (Underactive Thyroid) — Symptoms
Question 80
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.C.8 Biostatistical, epidemiological, or pharmacoeconomic measures · Fill in the blank
In a trial, the primary outcome occurred in 20% of the control group and 15% of the treatment group. What is the relative risk reduction?
Your answer: ______ %
Round the final answer to the nearest WHOLE number. Answer must be numeric.
Reveal answer and explanation for question 80
Correct answer: 25 %. Absolute risk reduction = 20% − 15% = 5%. Relative risk reduction = ARR ÷ control event rate = 5% ÷ 20% = 25%. (Equivalently, RR = 15/20 = 0.75, and RRR = 1 − 0.75 = 0.25.)
Remember: RRR = ARR ÷ control rate. NNT = 1 ÷ ARR.
Source: Worked calculation from the values in the question.
Question 81
Domain 2: Medication Use Process · 2.D Medication handling, storage, stability, and disposal · Multiple choice
How should a patient store dabigatran (Pradaxa) capsules that come in a bottle?
Reveal answer and explanation for question 81
Correct answer: A. Dabigatran capsules are sensitive to moisture. Labeling says to keep them in the original bottle or blister, close the bottle tightly, and discard capsules remaining 4 months after first opening the bottle.
Why the other options are wrong:
- B: Pill organizers expose capsules to moisture.
- C: Refrigeration isn't the labeled storage.
- D: Opening capsules can greatly increase absorption and bleeding risk; labeling says to swallow them whole.
Remember: Dabigatran: original container, 4 months after opening, swallow whole.
Source: Pradaxa (dabigatran) prescribing information (DailyMed) — Section 16 and Section 2
Question 82
Domain 3: Person-Centered Assessment and Treatment Planning · 3.E.3 Disease state management · Multiple choice
A patient with diabetes who is alert and able to swallow checks his blood glucose and gets 62 mg/dL. He feels shaky. What should he do first?
Reveal answer and explanation for question 82
Correct answer: A. The ADA Standards of Care in Diabetes—2026 recommend treating hypoglycemia at 70 mg/dL or less with fast-acting carbohydrate. For most individuals, 15 g of carbohydrate is the initial treatment; glucose should be rechecked 15 minutes later and treatment repeated if hypoglycemia persists.
Why the other options are wrong:
- B: Fat and protein in a large meal slow correction.
- C: Insulin would lower glucose further.
- D: Delaying treatment risks severe hypoglycemia.
Remember: For most alert patients: 15 g fast carbohydrate, recheck in 15 minutes, repeat if still low.
Source: ADA Standards of Care in Diabetes—2026: Glycemic Goals, Hypoglycemia, and Hyperglycemic Crises — Hypoglycemia Treatment
Question 83
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.F Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources · Multiple choice
A breastfeeding patient asks whether her new antidepressant passes into breast milk. Which free NIH database is designed to answer this question?
Reveal answer and explanation for question 83
Correct answer: A. LactMed, from the National Library of Medicine, summarizes data on drug levels in breast milk and infant blood, possible effects on breastfed infants, and alternatives.
Why the other options are wrong:
- B: The Orange Book covers approvals and equivalence ratings.
- C: ClinicalTrials.gov is a registry of studies, not a summary of lactation data.
- D: VAERS is a vaccine adverse event reporting system.
Remember: Lactation questions: LactMed.
Source: Drugs and Lactation Database (LactMed), NCBI Bookshelf — About LactMed
Question 84
Domain 2: Medication Use Process · 2.A.2 Indications, usage, and dosing regimens · Multiple choice
What is the usual oseltamivir dose to treat influenza in an adult with normal kidney function?
Reveal answer and explanation for question 84
Correct answer: A. Oseltamivir labeling lists 75 mg twice daily for 5 days to treat influenza in adults and adolescents 13 and older. 75 mg once daily is the prophylaxis dose.
Why the other options are wrong:
- B: Once daily is the prophylaxis schedule (typically for 10 days after exposure).
- C: This is not a labeled regimen.
- D: 30 mg doses are used for small children or renal adjustment.
Remember: Oseltamivir: treatment 75 mg BID × 5 days; prophylaxis 75 mg daily.
Source: Tamiflu (oseltamivir) prescribing information (DailyMed) — Section 2, Dosage and Administration
Question 85
Domain 3: Person-Centered Assessment and Treatment Planning · 3.A Medication history, allergy history, and reconciliation · Multiple choice
Which description best matches medication reconciliation as defined by The Joint Commission's National Patient Safety Goals?
Reveal answer and explanation for question 85
Correct answer: C. The Joint Commission's goal on medication information (NPSG.03.06.01) calls for obtaining the patient's current medications and comparing them with those ordered, so omissions, duplications, dosing errors, and interactions can be resolved.
Why the other options are wrong:
- A: Coverage checks are not reconciliation.
- B: Controlled substance counts are an inventory control.
- D: Cost review is a formulary activity.
Remember: Reconciliation: collect the list, compare with new orders, resolve differences, communicate the updated list.
Source: The Joint Commission, National Patient Safety Goals — NPSG.03.06.01
Question 86
Domain 1: Foundational Knowledge for Pharmacy Practice · 1.A.2 Pharmacokinetics, pharmacodynamics, or pharmacogenomics · Multiple choice
Which route of administration largely avoids hepatic first-pass metabolism?
Reveal answer and explanation for question 86
Correct answer: B. Drug absorbed under the tongue enters the systemic circulation directly and largely bypasses the portal circulation. That is why sublingual nitroglycerin works quickly even though oral nitroglycerin undergoes extensive first-pass metabolism.
Why the other options are wrong:
- A: Swallowed drugs pass through the liver via the portal vein first.
- C: An oral solution is still absorbed from the GI tract into the portal circulation.
- D: Enteric coating changes where the drug is released, not whether it passes the liver.
Remember: Bypass first pass: sublingual, buccal, IV, transdermal, inhaled.
Source: Nitrostat prescribing information (DailyMed) — Section 12.3, Pharmacokinetics
Question 87
Domain 2: Medication Use Process · 2.A.4 Prescription regulations · Multiple choice
A patient has prescriptions for oxycodone and alprazolam from different prescribers. What risk does the opioid boxed warning highlight for this combination?
Reveal answer and explanation for question 87
Correct answer: D. Opioid labeling carries a boxed warning that concomitant use with benzodiazepines or other CNS depressants can cause profound sedation, respiratory depression, coma, and death. Use together should be limited to patients without alternatives, at the lowest doses and shortest durations.
Why the other options are wrong:
- A: Serotonin syndrome is not the boxed risk for this combination.
- B: The combination lowers, not raises, respiratory and CNS function.
- C: Hepatotoxicity is not the risk named in this warning.
Remember: Opioid + benzodiazepine = respiratory depression box. Coordinate with prescribers; consider naloxone.
Source: Oxycodone hydrochloride tablets prescribing information (DailyMed) — Boxed Warning
Question 88
Domain 3: Person-Centered Assessment and Treatment Planning · 3.B Health histories, screenings, and assessments · Multiple choice
At a pharmacy screening, the average of two properly measured readings for an adult is 134/78 mm Hg. How is this classified under the 2025 AHA/ACC high blood pressure guideline?
Reveal answer and explanation for question 88
Correct answer: C. The 2025 guideline kept the 2017 categories: normal <120/<80, elevated 120-129/<80, stage 1 130-139 or 80-89, and stage 2 ≥140 or ≥90. A systolic value of 134 puts this reading in stage 1, even though the diastolic value is under 80. A diagnosis still requires confirmation across visits or with out-of-office readings.
Why the other options are wrong:
- A: Systolic 134 is above the normal range.
- B: Elevated requires systolic 120-129.
- D: Stage 2 requires ≥140 systolic or ≥90 diastolic.
Remember: Classify by the higher category of systolic or diastolic.
Source: 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults — BP classification
Question 89
Domain 4: Professional Practice · 4.D Ethical considerations · Multiple choice
An adult patient with full decision-making capacity declines a statin after the pharmacist explains its benefits and risks. Which ethical principle is the pharmacist honoring by respecting the decision?
Reveal answer and explanation for question 89
Correct answer: C. Autonomy is respect for a capable person's right to make informed decisions about their own care. The APhA Code of Ethics states that a pharmacist respects the autonomy and dignity of each patient.
Why the other options are wrong:
- A: Beneficence is acting for the patient's good, which here might argue for the statin.
- B: Justice concerns fair distribution of resources and care.
- D: Nonmaleficence is avoiding harm.
Remember: Informed refusal by a capable adult = autonomy.
Source: APhA Code of Ethics for Pharmacists — Principle II
Question 90
Domain 3: Person-Centered Assessment and Treatment Planning · 3.C.3 Interactions · Multiple choice
A patient stable on lithium for bipolar disorder is prescribed hydrochlorothiazide for hypertension. What is the expected effect?
Reveal answer and explanation for question 90
Correct answer: C. Thiazide diuretics reduce renal lithium clearance, which raises lithium levels. Lithium labeling warns of this interaction; if the combination is used, levels should be monitored closely and the lithium dose may need to be lowered.
Why the other options are wrong:
- A: The change goes the other way.
- B: This is a well-known, clinically significant interaction.
- D: Lithium, not the diuretic, is the drug affected.
Remember: Thiazides, ACE inhibitors, ARBs, and NSAIDs raise lithium levels.
Source: Lithium carbonate prescribing information (DailyMed) — Section 7, Drug Interactions
Question 91
Domain 2: Medication Use Process · 2.A.5 Safety and effectiveness · Multiple choice
A patient will receive linezolid for 3 weeks for a resistant infection. Which laboratory monitoring does linezolid labeling recommend?
Reveal answer and explanation for question 91
Correct answer: C. Linezolid can cause myelosuppression (anemia, leukopenia, pancytopenia, thrombocytopenia), especially with longer courses. Labeling recommends weekly complete blood counts.
Why the other options are wrong:
- A: Digoxin levels aren't related to linezolid.
- B: INR isn't a linezolid monitoring parameter.
- D: TSH isn't a linezolid monitoring parameter.
Remember: Linezolid: weekly CBC, and watch serotonergic drugs.
Source: Zyvox (linezolid) prescribing information (DailyMed) — Section 5, Myelosuppression
Question 92
Domain 3: Person-Centered Assessment and Treatment Planning · 3.D.2 Monitoring: safety · Multiple choice
A patient with chronic kidney disease starts lisinopril. Which two laboratory values should be checked soon after starting to monitor safety?
Reveal answer and explanation for question 92
Correct answer: B. ACE inhibitors reduce efferent arteriolar tone and aldosterone, so they can raise serum creatinine and potassium. Labeling warns about hyperkalemia and changes in renal function, which is why both are checked after starting or increasing the dose.
Why the other options are wrong:
- A: Blood counts aren't the main ACE inhibitor safety labs.
- C: Liver enzymes aren't routinely the key labs.
- D: Uric acid and calcium aren't the key labs.
Remember: ACE inhibitor or ARB start: check SCr and K.
Source: Lisinopril tablets prescribing information (DailyMed) — Section 5, Impaired renal function; Hyperkalemia
Question 93
Domain 5: Pharmacy Management and Leadership · 5.D Mentorship and preceptorship · Multiple choice
A preceptor wants to give a pharmacy student useful feedback after a patient counseling session. Which approach is most effective?
Reveal answer and explanation for question 93
Correct answer: C. Effective feedback is timely, specific, based on first-hand observation, and focused on behavior that can change. Holding problems until a final evaluation or giving only general praise denies the learner a chance to improve.
Why the other options are wrong:
- A: Late feedback removes the chance to improve during the rotation.
- B: Vague praise doesn't tell the learner what to keep or change.
- D: Comparisons with peers aren't feedback on the learner's behavior.
Remember: Feedback: timely, specific, observed, behavior-focused.
Source: Ende J. Feedback in clinical medical education. JAMA. 1983;250:777-781 — Guidelines for giving feedback
Question 94
Domain 3: Person-Centered Assessment and Treatment Planning · 3.D.3 Monitoring: effectiveness · Multiple choice
An adult's levothyroxine dose was increased today for primary hypothyroidism. When should TSH be rechecked to assess the change?
Reveal answer and explanation for question 94
Correct answer: A. Levothyroxine has a long half-life, so steady state takes weeks. Labeling recommends monitoring TSH 6 to 8 weeks after any dose change in adults with primary hypothyroidism.
Why the other options are wrong:
- B: Too early for TSH to reflect the new dose.
- C: Annual checks are for stable patients, not right after a change.
- D: Waiting for symptoms risks months of over- or under-treatment.
Remember: Levothyroxine dose change → TSH in 6-8 weeks.
Source: Levothyroxine sodium tablets prescribing information (DailyMed) — Section 2, Monitoring TSH
Question 95
Domain 3: Person-Centered Assessment and Treatment Planning · 3.D.2 Monitoring: safety · Multiple response
Which monitoring does oral amiodarone labeling call for because of its organ toxicities? (Select ALL that apply.)
Reveal answer and explanation for question 95
Correct answer: A, B, D, E. Amiodarone can cause hypo- or hyperthyroidism, hepatic injury, pulmonary toxicity, and optic neuropathy or corneal deposits. Its labeling describes monitoring for each of these.
Why the other options are wrong:
- C: CK isn't routinely monitored for amiodarone.
- F: Uric acid isn't an amiodarone monitoring parameter.
Remember: Amiodarone: thyroid, liver, lungs, eyes (plus skin, ECG).
Source: Amiodarone hydrochloride tablets prescribing information (DailyMed) — Section 5, Warnings and Precautions
Question 96
Domain 3: Person-Centered Assessment and Treatment Planning · 3.E.1 Lifestyle modifications and health maintenance · Multiple choice
Under the Physical Activity Guidelines for Americans, how much moderate-intensity aerobic activity should adults aim for each week?
Reveal answer and explanation for question 96
Correct answer: D. The guidelines call for at least 150 to 300 minutes a week of moderate-intensity aerobic activity (or 75 to 150 minutes of vigorous activity), plus muscle-strengthening activity at least 2 days a week.
Why the other options are wrong:
- A: 60 minutes is below the minimum.
- B: The guideline gives a moderate-intensity option and does not require vigorous activity only.
- C: A step count isn't the federal guideline's target.
Remember: Adults: 150+ min moderate or 75+ min vigorous per week, plus strength training 2 days.
Source: Physical Activity Guidelines for Americans, 2nd edition (ODPHP) — Current guidelines for adults
Question 97
Domain 3: Person-Centered Assessment and Treatment Planning · 3.E.2 Medication use, storage, and disposal · Multiple choice
A patient receives nitroglycerin 0.4 mg sublingual tablets for the first time. Which counseling point is correct?
Reveal answer and explanation for question 97
Correct answer: D. Nitrostat labeling directs dissolving 1 tablet under the tongue at the first sign of an attack. If chest pain isn't improved or is worse 5 minutes after the first dose, patients should call emergency services. Another tablet may be taken every 5 minutes, up to 3 in 15 minutes.
Why the other options are wrong:
- A: Swallowed nitroglycerin is largely broken down by first-pass metabolism.
- B: Doses are taken one at a time, 5 minutes apart, not together.
- C: Tablets should stay in the original glass container, tightly capped.
Remember: SL NTG: 1 tablet; call 911 at 5 minutes if not better; max 3 in 15 minutes.
Source: Nitrostat prescribing information (DailyMed) — Section 2; Patient Counseling Information
Question 98
Domain 3: Person-Centered Assessment and Treatment Planning · 3.E.2 Medication use, storage, and disposal · Multiple choice
A patient starts a fluticasone propionate inhaler for asthma. What counseling point helps prevent oral thrush?
Reveal answer and explanation for question 98
Correct answer: A. Inhaled corticosteroids can cause oropharyngeal candidiasis. Labeling advises rinsing the mouth with water without swallowing after each dose to reduce this risk.
Why the other options are wrong:
- B: Inhaled corticosteroids are maintenance therapy and don't provide quick relief.
- C: Food has no role in thrush prevention.
- D: A brief breath hold is part of inhaler technique, but it does not prevent thrush.
Remember: Inhaled steroid: rinse and spit.
Source: Flovent HFA (fluticasone propionate) prescribing information (DailyMed) — Section 5, Local effects; Patient Counseling Information
Question 99
Domain 3: Person-Centered Assessment and Treatment Planning · 3.F Over-the-counter medications and dietary supplements · Multiple choice
A patient who uses a combined hormonal birth control pill asks about starting St. John's wort for low mood. What is the key concern?
Reveal answer and explanation for question 99
Correct answer: D. St. John's wort induces drug-metabolizing enzymes (including CYP3A4) and can lower levels of many drugs. NCCIH notes it can make birth control pills less effective, leading to breakthrough bleeding and unplanned pregnancy.
Why the other options are wrong:
- A: It lowers, not raises, hormone levels.
- B: The interaction is well documented.
- C: Hypoglycemia is not the concern.
Remember: St. John's wort = inducer: contraceptives, warfarin, cyclosporine, HIV drugs, and more.
Source: NCCIH, St. John's Wort — Safety: drug interactions
Question 100
Domain 3: Person-Centered Assessment and Treatment Planning · 3.G Devices to administer medications and self-monitoring tests · Multiple choice
Where should an adult inject an epinephrine auto-injector during anaphylaxis?
Reveal answer and explanation for question 100
Correct answer: A. Epinephrine auto-injector labeling directs injection into the anterolateral aspect of the thigh, through clothing if needed. Patients should not inject into the buttocks, hands, or feet, and should seek emergency care afterward.
Why the other options are wrong:
- B: The thigh is the labeled site.
- C: Injection into the buttock is warned against.
- D: Auto-injectors are not designed for abdominal injection.
Remember: Epinephrine auto-injector: outer thigh, through clothes if needed, then call 911.
Source: EpiPen (epinephrine injection) auto-injector prescribing information (DailyMed) — Section 2, Dosage and Administration
Show complete answer key and scoring instructions
Answer key and scoring
Score one point for each question answered exactly right. On multiple-response questions, you need every correct option and no incorrect ones for the point. On fill-in-the-blank questions, your number must match after the rounding the question asks for.
| Question | Answer | Domain | Outline area |
|---|---|---|---|
| 1 | C | 3 | 3.E.2 Medication use, storage, and disposal |
| 2 | 300 mL | 1 | 1.C.2 Quantities of drugs to be dispensed or administered |
| 3 | C | 2 | 2.A.1 Drug names and therapeutic classes |
| 4 | A | 1 | 1.B.1 Nonsterile preparations |
| 5 | B | 2 | 2.C.1 Immunizations: indications and scheduling |
| 6 | C, D, F | 3 | 3.C.2 Appropriateness of therapy |
| 7 | C | 3 | 3.C.4 Errors and omissions |
| 8 | 40 mL/min | 1 | 1.C.1 Patient parameters or laboratory measures |
| 9 | A, B, C, D | 2 | 2.A.4 Prescription regulations |
| 10 | B | 3 | 3.B Health histories, screenings, and assessments |
| 11 | A | 1 | 1.E Research design principles and biostatistics |
| 12 | C | 3 | 3.C.3 Interactions |
| 13 | D | 2 | 2.D Medication handling, storage, stability, and disposal |
| 14 | C | 1 | 1.A.2 Pharmacokinetics, pharmacodynamics, or pharmacogenomics |
| 15 | B, C, D | 3 | 3.C.1 Signs, symptoms, and findings of medical conditions |
| 16 | 200 mL/h | 1 | 1.C.3 Rates of administration |
| 17 | A | 2 | 2.C.2 Immunizations: contraindications and precautions |
| 18 | B, D, E | 3 | 3.C.6 Toxicologic exposures and overdoses |
| 19 | B | 1 | 1.D Drug development processes |
| 20 | B | 2 | 2.A.2 Indications, usage, and dosing regimens |
| 21 | 5600 mg | 3 | 3.A Medication history, allergy history, and reconciliation |
| 22 | D | 3 | 3.C.5 Adverse drug reactions |
| 23 | A | 4 | 4.A Adverse drug event reporting and medication error reporting |
| 24 | C, D | 2 | 2.A.3 Available dosage forms |
| 25 | A | 1 | 1.F Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources |
| 26 | C | 3 | 3.D.3 Monitoring: effectiveness |
| 27 | A | 3 | 3.C.3 Interactions |
| 28 | A | 2 | 2.B Therapeutic substitutions |
| 29 | 73 kg | 1 | 1.C.1 Patient parameters or laboratory measures |
| 30 | D | 3 | 3.E.2 Medication use, storage, and disposal |
| 31 | D | 1 | 1.B.2 Sterile preparations |
| 32 | B | 3 | 3.F Over-the-counter medications and dietary supplements |
| 33 | D | 2 | 2.C.3 Immunizations: storage and handling |
| 34 | 72 % | 3 | 3.C.7 Adherence |
| 35 | D | 5 | 5.B Inventory and supply management |
| 36 | C | 1 | 1.A.3 Pharmaceutics |
| 37 | B | 3 | 3.D.1 Therapeutic goals, clinical endpoints, and follow-up |
| 38 | C | 4 | 4.D Ethical considerations |
| 39 | C | 2 | 2.C.5 Immunizations: adverse reactions |
| 40 | D | 5 | 5.C Quality improvement activities |
| 41 | A | 3 | 3.G Devices to administer medications and self-monitoring tests |
| 42 | 1.5 g | 1 | 1.C.6 Quantities of drugs or ingredients to be compounded |
| 43 | D | 2 | 2.A.4 Prescription regulations |
| 44 | D | 3 | 3.C.2 Appropriateness of therapy |
| 45 | A, B, C, D | 1 | 1.A.1 Pharmacology |
| 46 | B | 3 | 3.C.2 Appropriateness of therapy |
| 47 | B | 2 | 2.A.2 Indications, usage, and dosing regimens |
| 48 | 37.5 g | 1 | 1.C.5 Drug concentrations, ratio strengths, osmolarity, or osmolality |
| 49 | A | 3 | 3.C.2 Appropriateness of therapy |
| 50 | B, C, E | 2 | 2.A.3 Available dosage forms |
| 51 | D | 3 | 3.C.3 Interactions |
| 52 | D | 1 | 1.D Drug development processes |
| 53 | D | 2 | 2.A.5 Safety and effectiveness |
| 54 | C | 3 | 3.C.3 Interactions |
| 55 | 20 mEq | 1 | 1.C.5 Drug concentrations, ratio strengths, osmolarity, or osmolality |
| 56 | B | 4 | 4.B Public health initiatives and risk-prevention programs |
| 57 | B | 2 | 2.A.1 Drug names and therapeutic classes |
| 58 | D | 3 | 3.C.3 Interactions |
| 59 | D | 1 | 1.E Research design principles and biostatistics |
| 60 | B | 2 | 2.B Therapeutic substitutions |
| 61 | B | 3 | 3.C.4 Errors and omissions |
| 62 | 850 kcal | 1 | 1.C.7 Nutritional needs and the content of nutrient sources |
| 63 | A | 2 | 2.C.4 Immunizations: administration |
| 64 | B | 3 | 3.C.5 Adverse drug reactions |
| 65 | D | 5 | 5.C Quality improvement activities |
| 66 | 12.5 % | 1 | 1.C.9 Pharmacokinetic parameters |
| 67 | A | 2 | 2.C.5 Immunizations: adverse reactions |
| 68 | B | 3 | 3.C.5 Adverse drug reactions |
| 69 | C | 1 | 1.E Research design principles and biostatistics |
| 70 | B | 2 | 2.C.2 Immunizations: contraindications and precautions |
| 71 | C | 3 | 3.C.6 Toxicologic exposures and overdoses |
| 72 | B | 4 | 4.C Social determinants and drivers of health |
| 73 | 490 mg | 1 | 1.C.9 Pharmacokinetic parameters |
| 74 | B | 2 | 2.D Medication handling, storage, stability, and disposal |
| 75 | A, C, E | 3 | 3.C.6 Toxicologic exposures and overdoses |
| 76 | A | 5 | 5.A Pharmacy operations |
| 77 | A | 1 | 1.A.1 Pharmacology |
| 78 | C | 2 | 2.D Medication handling, storage, stability, and disposal |
| 79 | A, C, E, F | 3 | 3.C.1 Signs, symptoms, and findings of medical conditions |
| 80 | 25 % | 1 | 1.C.8 Biostatistical, epidemiological, or pharmacoeconomic measures |
| 81 | A | 2 | 2.D Medication handling, storage, stability, and disposal |
| 82 | A | 3 | 3.E.3 Disease state management |
| 83 | A | 1 | 1.F Retrieval, assessment, and interpretation of primary, secondary, and tertiary resources |
| 84 | A | 2 | 2.A.2 Indications, usage, and dosing regimens |
| 85 | C | 3 | 3.A Medication history, allergy history, and reconciliation |
| 86 | B | 1 | 1.A.2 Pharmacokinetics, pharmacodynamics, or pharmacogenomics |
| 87 | D | 2 | 2.A.4 Prescription regulations |
| 88 | C | 3 | 3.B Health histories, screenings, and assessments |
| 89 | C | 4 | 4.D Ethical considerations |
| 90 | C | 3 | 3.C.3 Interactions |
| 91 | C | 2 | 2.A.5 Safety and effectiveness |
| 92 | B | 3 | 3.D.2 Monitoring: safety |
| 93 | C | 5 | 5.D Mentorship and preceptorship |
| 94 | A | 3 | 3.D.3 Monitoring: effectiveness |
| 95 | A, B, D, E | 3 | 3.D.2 Monitoring: safety |
| 96 | D | 3 | 3.E.1 Lifestyle modifications and health maintenance |
| 97 | D | 3 | 3.E.2 Medication use, storage, and disposal |
| 98 | A | 3 | 3.E.2 Medication use, storage, and disposal |
| 99 | D | 3 | 3.F Over-the-counter medications and dietary supplements |
| 100 | A | 3 | 3.G Devices to administer medications and self-monitoring tests |
Your score by domain
| Domain | Questions in this test | Question numbers |
|---|---|---|
| 1. Foundational Knowledge for Pharmacy Practice | 25 | 2, 4, 8, 11, 14, 16, 19, 25, 29, 31, 36, 42, 45, 48, 52, 55, 59, 62, 66, 69, 73, 77, 80, 83, 86 |
| 2. Medication Use Process | 25 | 3, 5, 9, 13, 17, 20, 24, 28, 33, 39, 43, 47, 50, 53, 57, 60, 63, 67, 70, 74, 78, 81, 84, 87, 91 |
| 3. Person-Centered Assessment and Treatment Planning | 40 | 1, 6, 7, 10, 12, 15, 18, 21, 22, 26, 27, 30, 32, 34, 37, 41, 44, 46, 49, 51, 54, 58, 61, 64, 68, 71, 75, 79, 82, 85, 88, 90, 92, 94, 95, 96, 97, 98, 99, 100 |
| 4. Professional Practice | 5 | 23, 38, 56, 72, 89 |
| 5. Pharmacy Management and Leadership | 5 | 35, 40, 65, 76, 93 |
| Total | 100 |
Your percentage is your result on these 100 practice items. It is not a NAPLEX scaled score, and it can't tell you whether you'll pass. Domains 4 and 5 have only five questions each here, so read those two results as a rough signal, not a measurement.
How this practice test compares with the real NAPLEX
| Row label | Real NAPLEX | This practice test |
|---|---|---|
| Questions | 225; 200 count toward your result and 25 are unscored pretest questions | 100, all scored |
| Content | NAPLEX Content Outline, effective May 1, 2025 | Same five domains in the same proportions |
| Time | 6 hours (about 96 seconds per question) | Untimed; at the real exam's pace, 100 questions take about 2 hours 40 minutes |
| Question formats | Multiple choice, multiple response, and numeric fill-in-the-blank appear in NABP's sample items | The same three formats |
| Moving through the exam | Answer in order; no skipping; no going back once you confirm an answer | You can review and change answers |
| Result | Pass or fail | Your raw score, by domain |
| Questions come from | NABP's secure item pool | Original questions written for this page |
Sources: NABP NAPLEX Test Day Information (225 questions, 6 hours, fixed form, pass/fail); NABP Bulletin, What Is the NAPLEX? (answer in order, no skipping, no going back); NAPLEX Content Outline (domain weights across 200 scored questions); NAPLEX Sample Questions (formats). The seconds-per-question and 2-hour-40-minute figures are our arithmetic: 360 minutes ÷ 225 questions = 96 seconds, and 100 × 96 seconds = 160 minutes.
If you want to rehearse the real exam's rhythm, take a block of questions in order without going back, and keep an eye on a 96-seconds-per-question pace.
Is there an official free NAPLEX practice test?
Not a full-length one. NABP's free materials are its three-question sample items document, which shows the question formats, and two classified sample questions inside the Content Outline. NABP's official practice exam, the Pre-NAPLEX, costs $90 per attempt. It has 100 questions taken from previous NAPLEX exams, a 140-minute time limit, a total scaled score, a limit of 2 purchases per year, and a 7-day window to take it after you buy it.
One way to use both: take this free test first to find your weak domains, then save the Pre-NAPLEX for a checkpoint closer to test day. The Pre-NAPLEX is NABP's official practice exam for individual candidates and uses questions from past NAPLEX exams. NABP also offers NAPLEX Advantage through participating colleges of pharmacy; that separate proctored assessment also uses past NAPLEX questions. That's our suggestion about timing, not an NABP recommendation.
How to use your results
- Read every explanation you missed, and every one you guessed right. A lucky guess hides a gap just as well as a wrong answer shows one.
- Sort your misses into two piles. Some are knowledge gaps (you didn't know the rule). Others are process errors (you misread the stem, skipped a unit, or rounded too early). They need different fixes.
- Start with your weakest large domain. Domain 3 is 40% of the scored NAPLEX, so a weak Domain 3 costs far more than a weak Domain 5.
- Retry only your missed questions after a day or two, without looking at the explanations first.
- Check the source link on any rule that surprised you. Labels and guidelines change; the linked source is the authority, not this page.
For the exam's cost, retake rules, test-day rules, and a study-time plan built on the five domain weights, see our NAPLEX exam prep guide. Most candidates also need a pharmacy law exam; our MPJE and UMPJE guide covers which one applies to you.
Frequently asked questions
Are these real NAPLEX questions?
No. Every question here is original, written for this page and mapped to NABP's published Content Outline. NABP prohibits sharing or acquiring NAPLEX and Pre-NAPLEX questions, and we don't use recalled or leaked items.
Why 100 questions?
100 is a length that matches NABP's domain weights exactly on whole questions (25, 25, 40, 5, and 5), and it's long enough to show a pattern across all five domains. It is not a full-length simulation; the real exam has 225 questions.
Does a high score here mean I'll pass?
No. This test hasn't been statistically linked to NAPLEX results, so no score on it predicts a pass or a fail. Use it to find what to study next.
Sources and how we built this test
Exam facts: NAPLEX format, content domains and weights, question formats, and Pre-NAPLEX details come from NABP's NAPLEX page, Test Day Information, Candidate Application Bulletin, NAPLEX Content Outline, NAPLEX Sample Questions, and Pre-NAPLEX page.
Answers: Each explanation links to the source that supports the answer, such as FDA-approved prescribing information on DailyMed, CDC or FDA guidance, the USP compounding standard, or the relevant clinical guideline. The Content Outline tells us which topics belong on the test; it isn't used as proof that an answer is clinically correct.
How it was made: The Castleport Test Prep Editorial Team wrote these questions with AI assistance and classified each one to the NAPLEX Content Outline. Each explanation includes the source used for the underlying rule, label fact, calculation, or guideline point. No licensed pharmacist has reviewed this set. If you find an error, please report it through our corrections page, and we'll fix it and log the change.
Last verified: NAPLEX format, content outline, and Pre-NAPLEX details were checked against NABP's pages on September 24, 2026.
Written by the Castleport Test Prep Editorial Team.
Castleport Test Prep is an independent exam prep publisher and is not affiliated with, endorsed by, or approved by the National Association of Boards of Pharmacy (NABP). NAPLEX and other exam names are used to identify the exams discussed; trademarks belong to their respective owners. The questions on this page are original and unofficial; they are not NAPLEX or Pre-NAPLEX questions.
Source-link update (September 25, 2026): Four citation URLs in the approved manuscript now return 404. The Levoxyl, interchangeable biosimilar, FDA drug shortages, and biotin links here point instead to current official pages from the same publishers that support those points. The replacement pages are not copies of the original URLs.